HYBRID EVENT: You can participate in person at Baltimore, Maryland, USA or Virtually from your home or work.
Heather Mathie, Speaker at Vaccine Research Conference
Oral Presentation
Heather Mathie, Roslin Institute, University of Edinburgh, United Kingdom

Vaccination is a key component in the control of animal pathogens that impact the livestock industry. However, deployable, efficacious vaccines remain unavailable for many prevalent diseases, particularly those requiring cell-mediated immunity, such as bovine tuberculosis (TB). I [....] » Read More

Irina Zyrianova, Speaker at Vaccine Research Conference
Oral Presentation
Irina Zyrianova, Institute for Innovative Biotechnologies in Animal Husbandry, Russian Federation

The aim of this study is the investigation of the polymorphism of the tax gene/Tax protein and pre-miRs-B (pre-miRNA genes of Bovine leukemia virus (BLV)) polymorphism and its relation to Enzootic Bovine Leukosis. Methods: Peripheral blood samples of 2 to 5 years old female Ho [....] » Read More

Afshona Anoyatbekova, Speaker at Vaccine Research Conference
Oral Presentation
Afshona Anoyatbekova, Federal Scientific Centre, Russian Federation

Introduction and objective: Along with the success of developing biological products of new generation the traditional vaccines, as well as hyperimmune sera, remain as the main means of preventing viral diseases in animals. However, there is a potential threat of the dissemi [....] » Read More

Khursheed Anwer, Speaker at Vaccine Research Conference
Oral Presentation
Khursheed Anwer, IMUNON, Inc., United States

Nucleic acid-based vaccines represent an attractive alternative to live attenuated and subunit-based vaccines due to their capacity to trigger both humoral and cellular immunity and potential for low-cost and shortened production processes. The fast-track approval and the worldwi [....] » Read More

Alessia Quatela, Speaker at Vaccine Research Conference
Oral Presentation
Alessia Quatela, HORIBA Scientific, France

We will present several examples to highlight the capabilities of the fluorescence A-TEEM method, a novel approach which combines UV/Vis with fluorescence EEM spectroscopy. The benefit of this approach is the ability to provide robust and rapid spectroscopic characterization of v [....] » Read More

Huang Wei Ling, Speaker at Vaccine Research Conference
Oral Presentation
Huang Wei Ling, Medical Acupuncture And Pain Management Clinic, Brazil

In this theme the author will discuss various explanations that was used or not to implement this kind of rules in Europe and in many countries nowadays. Purpose; to demonstrate that using only this type of measures to control the spread of the virus, will not be reducinf [....] » Read More

Huang Wei L, Speaker at Immunology Conferences
Oral Presentation
Huang Wei L, Medical Acupuncture and Pain Management Clinic, Brazil

This process is not very easy to explain in the eyes of Western medicine and the author will explain it from the perspective of traditional Chinese medicine, following the commandments of Hippocrates, father of medicine. In an article written by the author entitled Is SARS-C [....] » Read More

Luiza Guilherme, Speaker at Vaccine Research Conference
Oral Presentation
Luiza Guilherme, University of Sao Paulo, Brazil

StreptInCor, a candidate vaccine against S. pyogenes is based on protective 55 amino acids residues of C-terminal portion of the M protein.  Experimental assays have demonstrated that the StreptInCor peptide induces high titers of opsonic and neutralizing and prote [....] » Read More

Alibek Adil, Speaker at Vaccine Research Conference
Oral Presentation
Alibek Adil, Kazakh-Russian Medical University, Kazakhstan

There is no doubt that vaccines are the most effective solution against the global challenges that pandemic brought to the world. In addition, thousands of studies all around the web are publishing the succeed results and social media is spreading them rapidly. Nevertheless, ther [....] » Read More

Idania Marrero, Speaker at Immunology Conferences
Oral Presentation
Idania Marrero, Inovio Pharmaceuticals Inc, United States

Lassa fever (LF) is an acute viral haemorrhagic disease caused by Lassa virus (LASV), which is endemic in Western Africa and is associated with high rates of infection and mortality. Currently, there are limited treatment options and no licensed vaccines to protect against LASV i [....] » Read More

Hao Song, Speaker at Vaccine Research Conference
Oral Presentation (In-person)
Hao Song, The University of Queensland, Australia

Recent advances in nanotechnology has greatly boosted the development of drug delivery systems for therapeutic and vaccine applications, in particular the great success in nanoparticle-based mRNA vaccines for COVID-19. To be noted, rational design and fabrication of safe and effi [....] » Read More

Patricia Canteri de Souza, Speaker at Vaccines Conferences
Oral Presentation (In-person)
Patricia Canteri de Souza, State University of Londrina, Brazil

Iron is essential for the functionality of biological processes, however, excess iron is toxic. In humans, due to its toxicity, this metal is found coupled to proteins, such as transferrin, which transports iron to tissues, and ferritin, an intracellular storage molecule of this [....] » Read More

Gaurav Joshi, Speaker at Immunology Conferences
Poster Presentation (In-person)
Gaurav Joshi, Texas Tech University, United States

To prevent next flu pandemics and to reduce the burden of seasonal flu infections, there is an urgent need to develop vaccines that are broadly protective against different influenza strains. In this regard we investigated polymeric nanoparticles as antigen carriers of a highly c [....] » Read More

Domenico Merante, Speaker at Immunology Conferences
Poster Presentation (In-person)
Domenico Merante, Global Clinical Development, Switzerland

History teaches us all about the course of past pandemics and the importance of the use of effective and safe vaccines to contribute to prevent diffuse bacterial and viral infections. But vaccines have also generated ethical controversies over the years. It is important to learn [....] » Read More

Azadeh Zahmatkesh, Speaker at Immunology Conferences
Poster Presentation (In-person)
Azadeh Zahmatkesh, Razi Vaccine and Serum Research Institute, Iran (Islamic Republic of)

Toll-like receptors (TLRs) are essential for activation of innate immunity and initiation of adaptive immune response. They have been associated with several respiratory diseases, but information on the relation of TLRs with SARS-CoV-2 still needs to be completed. Endosomal TLRs [....] » Read More

Julia Bespyatykh, Speaker at Immunology Conferences
Oral Presentation
Julia Bespyatykh, Federal Research and Clinical Centre of Physical-Chemical Medicine, Russian Federation

Mycobacterium tuberculosis is one of the most dangerous pathogens. Bacterial resistance to antituberculosis drugs grows each year, but searching for new drugs is a long process. Testing for available drugs to find active against mycobacteria may be a good alternative. In the [....] » Read More

Lamiae Grimaldi Bensouda, Speaker at Immunology Conferences
Oral Presentation
Lamiae Grimaldi Bensouda, Paris Saclay-University, France

Rheumatoid arthritis (RA) is one of the most common chronic inflammatory autoimmune disease. Patients with RA have a significant increased risk of serious infection following treatment with disease- modifying   antirheumatic   drugs,   and  &nbs [....] » Read More

Maryam Touhidinia, Speaker at Immunology Conferences
Oral Presentation
Maryam Touhidinia, Yazd University, Iran (Islamic Republic of)

Immunoinformatics plays a key role in vaccine design and antibody production. In the past, antibody design and vaccine development are expensive and time-consuming. Nowadays, advances in the field of bioinformatics have provided practical tools that can be used to lessen the time [....] » Read More

Ghadir Fakhri Al Jayyousi, Speaker at Immunology Conferences
Oral Presentation
Ghadir Fakhri Al Jayyousi, Qatar University, Qatar

Major hindrances to getting a COVID-19 vaccine include vaccine hesitancy, skepticism, refusal, and anti-vaccine movements. Several studies have been conducted on attitudes of the public towards COVID-19 vaccines and the potential influencing factors. The purpose of this scoping r [....] » Read More

Sanjeeb Kumar Mishra, Speaker at Vaccines Conferences
Oral Presentation
Sanjeeb Kumar Mishra, Department Of Community Medicine, VIMSAR, India

Background – Since the day the Novel SARS Cov has been detected and the ensuing pandemic the search for a cure or prevention has been the only target of the medical fraternity. As the second wave racked havoc Vaccine seemed the only viable option to stop this global su [....] » Read More

Damini Singh, Speaker at Vaccines Conferences
Oral Presentation
Damini Singh, Environmental Pollution Analysis Lab, India

Brucellosis is a zoonotic bacterial infection of pandemic potential – caused by Brucella species. Lack of vaccines against human brucellosis despite continuous research has led us to address this issue using several selectively chosen antigens pertaining to B [....] » Read More

Mohammad Jalil Zorriehzahra, Speaker at Vaccines Conferences
Oral Presentation
Mohammad Jalil Zorriehzahra, Iranian Fisheries Science Research Institute, Iran (Islamic Republic of)

This fact is well known that the appearance and development of all fish disease process could be the result of the interaction between three parameters such as pathogen, host, and environment. Therefore, only multidisciplinary studies involving knowledge of the characteristics of [....] » Read More

K M Yacob, Speaker at Vaccines Conferences
Oral Presentation
K M Yacob, Marma Health Centre, India

The physicians are talking about the treatment of fever indifferently. They are talking about not to treat fever but for the underlying cause of fever. At the same time when people have a fever, they instruct to reduce fever urgently. The cause of fever and cause of disease [....] » Read More

Mahya Sadat Lajevardi, Speaker at Vaccines Conferences
Oral Presentation
Mahya Sadat Lajevardi, Pasteur Institute of Iran, Iran (Islamic Republic of)

To generate more effective subunit vaccines against complex organisms like Leishmania parasites, we need to fuse several immunogenic proteins together. However, the critical issue is that which arrangement of the constituting components should be selected as the favored [....] » Read More

Muhammad Naveed Anwar, Speaker at Vaccines Conferences
Oral Presentation
Muhammad Naveed Anwar, Chinese Academy of Agricultural Sciences, Pakistan

Japanese encephalitis (JE) is a vector-borne zoonotic viral disease caused by (Japanese encephalitis virus, JEV). Vaccination is the most effective way to control JE in both humans and pigs. However, JEV genotype shift that the dominant genotype III (GIII) has been replaced by ge [....] » Read More

M Jalil Zorriehzahra, Speaker at Vaccines Conferences
Oral Presentation
M Jalil Zorriehzahra, Iranian Fisheries Science Research Institute, Iran (Islamic Republic of)

During recent years we have witnessed numerous occurrences of viral infectious diseases such as Ebola, MERS, SARS, and recently COVID-19 with a drastic negative effect on human health. Following the outbreak of the COVID-19 pandemic, it has been declared a public health emergency [....] » Read More

Yacob Mathai, Speaker at Vaccines Conferences
Oral Presentation
Yacob Mathai, Marma Health Centre, India

All treatments for fever are based on the belief that fits is the result of 41 degrees Celsius temperature and it damages cells of the brain and body. At the same time, there is no evidence-based tests or concrete diagnosing methods to the belief that fits and brain damage i [....] » Read More

Ismail Hossain, Speaker at Vaccines Conferences
Oral Presentation
Ismail Hossain, Globe Biotech, Bangladesh

First of all I would like to discuss about the global pandemic covid 19 outbreak across the Whole World & how much impact on human after spreading this virus globally.Most of the peoples has been said its (virus) originated from china ,Wuhan state.whatever this virus was incr [....] » Read More

Jennifer Elaine Gerber, Speaker at Vaccines Conferences
Oral Presentation
Jennifer Elaine Gerber, Johns Hopkins Bloomberg School of Public Health, United States

Background: Vaccine coverage is lower for influenza than for other vaccines, varying by age, race/ethnicity, and region. Vaccine safety concerns are common despite a lack of epidemiological evidence. We characterized vaccine hesitancy and identified associations with influen [....] » Read More

Watsapp